Erik Bus

Minimal residual disease monitoring in neuroblastoma

D. Zwijnenburg, R. Versteeg, H. Caron, 2016 .

Whole-genome sequencing identifies patient-specific DNA minimal residual disease markers in neuroblastoma.

D. Zwijnenburg, R. Versteeg, H. Caron, 2015, The Journal of molecular diagnostics : JMD.

Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg

S. Middeldorp, B. Biemond, C. E. van der Schoot, 2011, Annals of Hematology.